medigraphic.com
Colegio de Medicina Interna de México.

2016, Number 2

<< Back Next >>

Med Int Mex 2016; 32 (2)

Neurocysticercosis in chronic kidney disease

Polanco NA

Language: Spanish
References: 16
Page: 249-255
PDF size: 500.01 Kb.


ABSTRACT

We report the case of a Mexican male patient, 66 years old, diabetic long standing, with substitution of renal function by hemodialysis, with persistent headache associated with nausea and feeling weak, without response to conventional analgesics. Cranial tomography evidenced brain imaging suggestive of cysticerci, which was confirmed by immunological test. Patient was treated with praziquantel and albendazol for two weeks whit symptoms disappearing.


REFERENCES

  1. Botero D. Teniasis-cisticercosis. En: Goldsmith R, Heyneman D, editores Parasitología y Medicina Tropical. México DF: Manual Moderno, 1995;632-646.

  2. Evans CAW, García HH, Gilman RH. Larval cestode infections: Cysticercosis. En: Strickland GT, editor. Hunter’s Tropical Medicine and Emerging Infectious Diseases. Philadelphia: WB Saunders, 1999;862-865.

  3. Bouteille B. Epidemiology of cysticercosis and neurocysticercosis. Med Sante Trop 2014;24:367-374.

  4. García H, González A, Martínez S, Gilman R. Teniasis/cisticercosis por Taenia solium: un serio problema de salud pública en el Perú. Oficina General de Epidemiología, Lima 2001;7-19.

  5. Flisser A. Risk factors and control measures for taeniosis/ cysticercosis. En: Craig P, Pawlowski Z, editors. Cestode Zoonoses: Echinococcosis and Cysticercosis, An emergent and global problem. Amsterdam: IOS Press, NATO Science Series 2002;341:335-342.

  6. Sorvillo F, Wilkins P, Shafir S, Eberhard M. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 2011;17:1-6.

  7. Secretaría de Salud. Modificación a la Norma Oficial Mexicana NOM-021-SSA2-1994, para la prevención y control del complejo teniosis/cisticercosis en el primer nivel de atención médica. México: Diario Oficial de la Federación; 2004. Disponible en: http://www.salud.gob.mx/unidades/ cdi/nom/ m021ssa294.html

  8. Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, Chávez Macías L, et al. Neurocysticercosis: radiologicpathologic correlation. Radiographics 2010;30:1705-1719.

  9. Del Brutto OH. Neurocisticercosis: actualización en diagnóstico y tratamiento. Neurología 2005;20:412-418.

  10. Náquira C. Taenia solium: biological cycle and characteristics. En: García HH, Martinez SM, editors. Taenia solium. Taeniasis/Cysticercosis. 2nd ed. Lima: Universo, 1999;7-14.4.

  11. Pawlowski Z, Allan J, Sarti E. Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. Int J Parasitol 2005;35:1221-1232.

  12. Vidal S. Comunicación de un caso de cisticercosis subcutánea. Rev Chilena Infectol 2013;30:323-325.

  13. Del Brutto OH, Rajshekhar V, White JR AC, Tsang VC, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-183.

  14. Sarria-Estrada S, Frascheri-Verzelli L, Siurana-Montilva S, Auger-Acosta C, Rovira-Cañellas A. Neurocisticercosis. Hallazgos radiológicos. Radiología 2013;55:130-141.

  15. Del Brutto OH. Neurocysticercosis. Neurohospitalist 2014;4:205-212.

  16. Garcia HH, Gonzales I, Lescano AG, Bustos JA, et al (Cysticercosis Working Group in Peru). Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis 2014;14:687-695.




2020     |     www.medigraphic.com